Mukta Mantan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mukta Mantan has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Akanksha Mahajan
Department of Pediatrics, Maulana Azad Medical College, New Delhi, India
10 shared publications Aashima Dabas
Department of Paediatrics, Maulana Azad Medical College & Associated Lok Nayak Hospital, New Delhi, India
6 shared publicationsBhawna Mahajan
Department of Biochemistry, GIPMER, University of Delhi, New Delhi 110002, India (Bhawna Mahajan)
6 shared publicationsAkanksha Mahajan
Department of Pediatrics, Maulana Azad Medical College & Lok Nayak Hospital, New Delhi, India
5 shared publicationsBinita Goswami
Department of Biochemistry, Maulana Azad Medical College and Lok Nayak Hospital, University of Delhi, New Delhi, India
5 shared publications- Aashima Dabas
Department of Pediatrics, Maulana Azad Medical College, New Delhi, India
4 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 164 (4) , 647-651
Seroprevalence of varicella antibodies in unvaccinated children with nephrotic syndrome in disease remission
Background and objectives: Varicella-zoster (VZV) virus infection can be severe in children with nephrotic syndrome. Lack of varicella vaccination through the national immunisation programme in India leaves many vulnerable to infection. We conducted this study to document the seroprevalence of Varicella antibodies in patients with nephrotic syndrome. Methods: This cross-sectional study (Oct 2024-May 2025) was conducted at a tertiary-care teaching hospital in India, in children (1-18 y) with nephrotic syndrome (both steroid-sensitive and steroid-resistant) in disease remission. Serum VZV IgG antibodies were measured using the EUROIMMUN ELISA kit; titres ≥100 IU/L were considered seroprotective. Results: 100 patients were enrolled (median age 8 y). None had received varicella vaccination, and only two reported prior infection. Overall seroprotection was 22% with a geometric mean titre of 9.472 IU/L [median (IQR) 7.59 (3.35; 73.38) IU/L]. No significant difference was observed in titres between steroid-sensitive and steroid-resistant nephrotic syndrome ( P =0.532), but seroprotection increased with age (11.1% in 10 y). Interpretation and conclusions: Low seroprevalence likely reflects the inadequacy of natural immunity and absence of routine varicella vaccination, warranting larger seroprevalence studies and future research on the need for priority immunisation for this high-risk population.
- 15 September 2026
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 164 (4) , 647-651
Open AccessSeroprevalence of varicella antibodies in unvaccinated children with nephrotic syndrome in disease remission
Background and objectives: Varicella-zoster (VZV) virus infection can be severe in children with nephrotic syndrome. Lack of varicella vaccination through the national immunisation programme in India leaves many vulnerable to infection. We conducted this study to document the seroprevalence of Varicella antibodies in patients with nephrotic syndrome. Methods: This cross-sectional study (Oct 2024-May 2025) was conducted at a tertiary-care teaching hospital in India, in children (1-18 y) with nephrotic syndrome (both steroid-sensitive and steroid-resistant) in disease remission. Serum VZV IgG antibodies were measured using the EUROIMMUN ELISA kit; titres ≥100 IU/L were considered seroprotective. Results: 100 patients were enrolled (median age 8 y). None had received varicella vaccination, and only two reported prior infection. Overall seroprotection was 22% with a geometric mean titre of 9.472 IU/L [median (IQR) 7.59 (3.35; 73.38) IU/L]. No significant difference was observed in titres between steroid-sensitive and steroid-resistant nephrotic syndrome ( P =0.532), but seroprotection increased with age (11.1% in 10 y). Interpretation and conclusions: Low seroprevalence likely reflects the inadequacy of natural immunity and absence of routine varicella vaccination, warranting larger seroprevalence studies and future research on the need for priority immunisation for this high-risk population.
- 18 August 2026
- Published by Springer Nature in International Urology and Nephrology
- p. 1-8
Profile of FGF23 and NTproBNP levels and their association with left ventricular hypertrophy in children and adolescents with CKD
Background While N-terminal pro-B-type natriuretic peptide (NTproBNP) and fibroblast growth factor 23 (FGF23) have independently been evaluated for identification of left ventricular hypertrophy (LVH) in adults, their utility in children is underexplored. Methods This cross-sectional study was conducted in children and adolescents (5–18 years) with CKD; those with severe anemia, congestive heart failure or congenital heart disease were excluded. Clinical assessment, hemogram, kidney function tests, and bone mineral metabolism parameters were recorded. Serum FGF23 was measured by ELISA and NTproBNP by chemiluminescence-based kits. Echocardiography was done in children (CKD stages 3–5) within 2 weeks of blood investigations. Results Of 60 patients with median (IQR) age 10 (7;12) years enrolled, hypertension was present in 28 (46.6%). NTproBNP was elevated in 40% and FGF23 in 60%. LVH was found in 12 (33.3%) out of the total 36 subjects in CKD stage 3–5. NTproBNP had a significant correlation with hypertension (p < 0.01). The sensitivity and specificity of NTproBNP, eGFR-adjusted NTproBNP and FGF23 to predict LVH were 91.7% and 65.2% (AUC 0.69), 91.7% and 52.2% (AUC 0.53), and 41.7% and 82.6% (AUC 0.51), respectively. Combined FGF23 and NTproBNP achieved sensitivity of 55% and specificity of 100% which was unchanged after eGFR adjustment. Conclusions NTproBNP showed a high sensitivity for predicting LVH, and the specificity nearly reached 100% when combining NTproBNP with FGF23, indicating its potential as a screening tool where availability of echocardiography is limited.
- 18 August 2026
- Published by Springer Nature in International Urology and Nephrology
- p. 1-8
Profile of FGF23 and NTproBNP levels and their association with left ventricular hypertrophy in children and adolescents with CKD
Background While N-terminal pro-B-type natriuretic peptide (NTproBNP) and fibroblast growth factor 23 (FGF23) have independently been evaluated for identification of left ventricular hypertrophy (LVH) in adults, their utility in children is underexplored. Methods This cross-sectional study was conducted in children and adolescents (5–18 years) with CKD; those with severe anemia, congestive heart failure or congenital heart disease were excluded. Clinical assessment, hemogram, kidney function tests, and bone mineral metabolism parameters were recorded. Serum FGF23 was measured by ELISA and NTproBNP by chemiluminescence-based kits. Echocardiography was done in children (CKD stages 3–5) within 2 weeks of blood investigations. Results Of 60 patients with median (IQR) age 10 (7;12) years enrolled, hypertension was present in 28 (46.6%). NTproBNP was elevated in 40% and FGF23 in 60%. LVH was found in 12 (33.3%) out of the total 36 subjects in CKD stage 3–5. NTproBNP had a significant correlation with hypertension (p < 0.01). The sensitivity and specificity of NTproBNP, eGFR-adjusted NTproBNP and FGF23 to predict LVH were 91.7% and 65.2% (AUC 0.69), 91.7% and 52.2% (AUC 0.53), and 41.7% and 82.6% (AUC 0.51), respectively. Combined FGF23 and NTproBNP achieved sensitivity of 55% and specificity of 100% which was unchanged after eGFR adjustment. Conclusions NTproBNP showed a high sensitivity for predicting LVH, and the specificity nearly reached 100% when combining NTproBNP with FGF23, indicating its potential as a screening tool where availability of echocardiography is limited.
- 16 June 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (8) , 1721-1722
Response to letter regarding article, “Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remission”
- 16 June 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (8) , 1721-1722
Response to letter regarding article, “Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remission”
- 27 April 2026
- Published by Springer Nature in Indian Pediatrics
- Vol. 63 (9) , 674-676
Continuous Ambulatory Blood Pressure Monitoring of Non-Dialyzed Children and Adolescents with Chronic Kidney Disease
Hypertension is a known complication and modifiable risk factor for chronic kidney disease (CKD). Diurnal variability is better assessed using continuous ambulatory blood pressure monitoring (CABPM). We enrolled 74 adolescents (78.4% boys) aged 10-18 years with CKD, excluding those on dialysis or with hypertensive urgency/emergency. Casual blood pressure and CABPM were measured using Omron oscillometric sphygmomanometer and A&D TM2441, respectively. Using CABPM, 12 (16.2%) had white coat hypertension, 7 (9.5%) had masked hypertension, and 14 (18.9%) had ambulatory hypertension. Twenty-eight (37.8%) children had blunted nocturnal dipping and 6.6% had left ventricular hypertrophy (LVH).
- 27 April 2026
- Published by Springer Nature in Indian Pediatrics
- Vol. 63 (9) , 674-676
Continuous Ambulatory Blood Pressure Monitoring of Non-Dialyzed Children and Adolescents with Chronic Kidney Disease
Hypertension is a known complication and modifiable risk factor for chronic kidney disease (CKD). Diurnal variability is better assessed using continuous ambulatory blood pressure monitoring (CABPM). We enrolled 74 adolescents (78.4% boys) aged 10-18 years with CKD, excluding those on dialysis or with hypertensive urgency/emergency. Casual blood pressure and CABPM were measured using Omron oscillometric sphygmomanometer and A&D TM2441, respectively. Using CABPM, 12 (16.2%) had white coat hypertension, 7 (9.5%) had masked hypertension, and 14 (18.9%) had ambulatory hypertension. Twenty-eight (37.8%) children had blunted nocturnal dipping and 6.6% had left ventricular hypertrophy (LVH).
- 13 April 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (6) , 667
Infantile Systemic Lupus Erythematosus Presenting as Membranous Lupus Nephritis
- 13 April 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (6) , 667
Infantile Systemic Lupus Erythematosus Presenting as Membranous Lupus Nephritis
- 24 March 2026
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (10) , 3365-3367
Recurrent pancreatitis and atypical hemolytic uremic syndrome (aHUS): an unusual presentation in childhood
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy characterized by the classical triad of acute hemolytic anemia, thrombocytopenia, and kidney impairment. We report a 10-year-old boy with acute pancreatitis presenting simultaneously with atypical HUS (aHUS) with two such episodes occurring 1 year apart. The child presented with abdominal pain, vomiting, oliguria, epigastric tenderness, and had a right undescended testis. During the initial episode, anti-factor H antibodies were mildly elevated while they were normal in the subsequent episode with normal complement components. Whole exome sequencing identified a heterozygous pathogenic CFTR variant, predisposing to recurrent pancreatitis and cryptorchidism, as well as a probable heterozygous CFHR1/CFHR3 deletion, the gene responsible for recurrent aHUS. Treatment of pancreatitis, hemodialysis, and plasma infusions led to complete recovery of acute kidney injury (AKI) and HUS on both occasions.
- 24 March 2026
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (10) , 3365-3367
Recurrent pancreatitis and atypical hemolytic uremic syndrome (aHUS): an unusual presentation in childhood
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy characterized by the classical triad of acute hemolytic anemia, thrombocytopenia, and kidney impairment. We report a 10-year-old boy with acute pancreatitis presenting simultaneously with atypical HUS (aHUS) with two such episodes occurring 1 year apart. The child presented with abdominal pain, vomiting, oliguria, epigastric tenderness, and had a right undescended testis. During the initial episode, anti-factor H antibodies were mildly elevated while they were normal in the subsequent episode with normal complement components. Whole exome sequencing identified a heterozygous pathogenic CFTR variant, predisposing to recurrent pancreatitis and cryptorchidism, as well as a probable heterozygous CFHR1/CFHR3 deletion, the gene responsible for recurrent aHUS. Treatment of pancreatitis, hemodialysis, and plasma infusions led to complete recovery of acute kidney injury (AKI) and HUS on both occasions.
- Open Access
- 12 February 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (4) , 419
Presence of Multiple Muscle Specific Autoantibodies (MSAs) in a Young Child with Juvenile Dermatomyositis
- 12 February 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (4) , 419
Open AccessPresence of Multiple Muscle Specific Autoantibodies (MSAs) in a Young Child with Juvenile Dermatomyositis
- 10 February 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (4) , 789-796
Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remission
- 10 February 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (4) , 789-796
Apolipoproteins, lipoprotein(a), and conventional markers of dyslipidemia in children with nephrotic syndrome in disease remission
- Open Access
- 20 November 2025
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (1) , 90
Chediak-Higashi Syndrome Complicated by Mucormycosis
- 20 November 2025
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (1) , 90
Open AccessChediak-Higashi Syndrome Complicated by Mucormycosis
- 28 October 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 56 (1) , 128-130
Rare but real: Unusual manifestations of hepatitis A
Hepatitis A is usually a self-limiting infection in children, commonly presenting with jaundice. However, rare extra-hepatic manifestations may complicate the course, including cardiac and pancreatic involvement. We report two paediatric cases of hepatitis A virus (HAV) infection with such atypical presentations. A 6-year-old boy presented with lethargy, vomiting, and bradycardia; an electrocardiogram revealed complete heart block progressing to Mobitz type I block, with bilateral pleural effusion. Also, a 10-year-old boy presented with acute abdominal pain and was found to have elevated pancreatic enzymes and imaging findings consistent with pancreatitis. Both improved with conservative management. These cases highlight the importance of recognising unusual systemic complications of HAV. They also reinforce the urgent need to integrate hepatitis A vaccination into the national immunisation schedule in India.
- 28 October 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 56 (1) , 128-130
Rare but real: Unusual manifestations of hepatitis A
Hepatitis A is usually a self-limiting infection in children, commonly presenting with jaundice. However, rare extra-hepatic manifestations may complicate the course, including cardiac and pancreatic involvement. We report two paediatric cases of hepatitis A virus (HAV) infection with such atypical presentations. A 6-year-old boy presented with lethargy, vomiting, and bradycardia; an electrocardiogram revealed complete heart block progressing to Mobitz type I block, with bilateral pleural effusion. Also, a 10-year-old boy presented with acute abdominal pain and was found to have elevated pancreatic enzymes and imaging findings consistent with pancreatitis. Both improved with conservative management. These cases highlight the importance of recognising unusual systemic complications of HAV. They also reinforce the urgent need to integrate hepatitis A vaccination into the national immunisation schedule in India.